This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yang, J. Articles by Ogihara, T. Search for Related Content PubMed PubMed Citation Articles by Yang, J. Articles by Ogihara, T. Related Collections Hypertension - basic studies Endothelium/vascular type/nitric oxide

(Hypertension. 2000;35:82.)
© 2000 American Heart Association, Inc.

Scientific Contributions

Pranidipine Enhances the Action of Nitric Oxide Released From Endothelial Cells

Jin Yang; Keisuke Fukuo; Shigeto Morimoto; Tadaaki Niinobu; Toshimitsu Suhara; Toshio Ogihara

From the Department of Geriatric Medicine, Osaka University Medical School (Japan).

Correspondence to Keisuke Fukuo, MD, Department of Geriatric Medicine, Osaka University Medical School, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan. E-mail fukuo{at}geriat.med.osaka-u.ac.jp

Abstract—Nitric oxide (NO) synthesis in vascular endothelium of patients with hypertension is altered. Calcium antagonists have been shown to improve endothelial function in hypertensive patients. Here we report that pranidipine, one of the latest long-acting calcium antagonists in the dihydropyridine group, enhances the actions of NO released from endothelial cells (ECs). Pranidipine significantly enhanced cGMP accumulation in vascular smooth muscle cells cocultured with ECs, whereas amlodipine and nifedipine had no significant effects. In addition, pranidipine also suppressed basal and thrombin-stimulated endothelin-1 production from ECs. Pranidipine also enhanced cGMP accumulation in rat aortic segments with endothelium but not in endothelium-denuded vessels. In contrast, pranidipine had no effect in the presence of N^G-monomethyl-L-arginine, an inhibitor of NO synthesis. Pranidipine did not affect the basal expression of endothelial NO synthase in ECs. However, pranidipine upregulated the activity of superoxide dismutase in ECs. These findings suggest that pranidipine enhances NO action through inhibition of superoxide-induced NO decomposition in the vessel wall. Thus, pranidipine may be useful in the treatment of impaired endothelial function in patients with hypertension.

Key Words: calcium antagonists • nitric oxide • endothelin • superoxide

This article has been cited by other articles:

				L. J. Ignarro, C. Napoli, and J. Loscalzo Nitric Oxide Donors and Cardiovascular Agents Modulating the Bioactivity of Nitric Oxide: An Overview Circ. Res., January 11, 2002; 90(1): 21 - 28. [Abstract] [Full Text] [PDF]

				P. Krenek, S. Salomone, J. Kyselovic, M. Wibo, N. Morel, and T. Godfraind Lacidipine Prevents Endothelial Dysfunction in Salt-Loaded Stroke-Prone Hypertensive Rats Hypertension, April 1, 2001; 37(4): 1124 - 1128. [Abstract] [Full Text] [PDF]